Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

Autor:	Granger, M. Meaghan, Naranjo, Arlene, Bagatell, Rochelle, DuBois, Steven G., McCune, Jeannine S., Tenney, Sheena C., Weiss, Brian D., Mosse, Yael P., Asgharzadeh, Shahab, Grupp, Stephen A., Hogarty, Michael D., Gastier-Foster, Julie M., Mills, Denise, Shulkin, Barry L., Parisi, Marguerite T., London, Wendy B., Han-Chang, John, Panoff, Joseph, von Allmen, Daniel, Jarzembowski, Jason A., Park, Julie R., Yanik, Gregory A.
Zdroj:	In Transplantation and Cellular Therapy June 2021 27(6):490-490
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect